← Product Code [IMI](/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/IMI) · K021483 # RICH-MAR THERASOUND 6.5 THERAPEUTIC ULTRASOUND (K021483) _Rich-Mar Corp. · IMI · Sep 13, 2002 · Physical Medicine · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/IMI/K021483 ## Device Facts - **Applicant:** Rich-Mar Corp. - **Product Code:** [IMI](/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/IMI.md) - **Decision Date:** Sep 13, 2002 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 890.5300 - **Device Class:** Class 2 - **Review Panel:** Physical Medicine - **Attributes:** Therapeutic ## Indications for Use Rich-Mar ultrasound devices are indicated to produce therapeutic deep heat for the following conditions: - Relief of pain - Muscle spasms - Joint contractures But NOT for the treatment of malignancies ## Device Story Rich-Mar Therasound 6.5 is a therapeutic ultrasound device used in clinical settings by healthcare professionals. It delivers ultrasonic energy to tissues to produce deep heat. The device is indicated for pain relief, muscle spasms, and joint contractures. It is not intended for treating malignancies. Operation involves applying the ultrasound transducer to the patient's skin to facilitate thermal effects in deep tissues, aiding in physical therapy and rehabilitation. ## Clinical Evidence Bench testing only. ## Technological Characteristics Therapeutic ultrasound device; Class II; Product Code IMI; 21 CFR 890.5300. Operates via ultrasonic energy for deep tissue heating. ## Regulatory Identification An ultrasonic diathermy for use in applying therapeutic deep heat for selected medical conditions is a device that applies to specific areas of the body ultrasonic energy at a frequency beyond 20 kilohertz and that is intended to generate deep heat within body tissues for the treatment of selected medical conditions such as relief of pain, muscle spasms, and joint contractures, but not for the treatment of malignancies. ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ ## DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three lines forming its body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular pattern around the eagle. ## Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 ## SFP 1 3 2002 Ken Coffey President/CEO Rich-Mar Corporation P.O. Box 879 Inola. Oklahoma 74036 Re: K021483 Trade/Device Name: Rich-Mar Therasound 6.5 Therapeutic Ultrasound Regulation Number: 21 CFR 890.5300 Regulation Name: Ultrasonic Diathermy Regulatory Class: Class II Product Code: IMI Dated: August 20, 2002 Received: August 21, 2002 Dear Mr. Coffey: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {1}------------------------------------------------ Page 2 – Mr. Ken Coffey This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely vours, L. Mark N. Millman Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ Rich-Mar 510(k) for Therasound 6.5 of 1 Page } 510(k) Number (if known): Device Name: Rich-Mar Therasound 6.5 Indications For Use: Rich-Mar ultrasound devices are indicated to produce therapeutic deep heat for the following conditions: - Relief of pain ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ - Muscle spasms 2. - Joint contractures 3. But NOT for the treatment of malignancies ## (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED Concurrence of CDRH, Office of Device Evaluation (ODE) for Mark N. Milliken (Division Sign-Off Division of Gener estorative .nd Neurological l . Pres K021483 510(k) Number Section 14 - Required Certification Statements 14.4 --- **Source:** [https://fda.innolitics.com/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/IMI/K021483](https://fda.innolitics.com/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/IMI/K021483) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com